When patients with hypothyroidism or Hashimoto’s adopt the lectin-free low-carb approach in my book The 30-Week Tirzepatide Reset, certain blood markers shift predictably. After 4–6 weeks, TSH often rises 0.5–2.0 mIU/L because the body conserves energy on fewer carbohydrates, while free T3 and free T4 may drop 10–15% before stabilizing. Reverse T3 frequently increases as the liver slows conversion. These are adaptive responses, not failure, provided symptoms improve and inflammation markers fall.
In our clinic, we track a full thyroid panel plus metabolic markers every 8–10 weeks. On the 221-recipe lectin-free plan combined with low-dose tirzepatide cycling, most 45–54-year-olds see CRP drop below 1.0 mg/L, fasting insulin under 8 μIU/mL, and HbA1c improve by 0.5–1.5 points. Total cholesterol and LDL often rise 20–40% while HDL climbs and triglycerides fall below 100 mg/dL. This pattern, sometimes called the “lean mass hyper-responder” profile, is common in those losing 30–60 lbs and rarely requires statins when inflammatory markers are low. Thyroid antibody levels (TPO and TgAb) typically decline 30–50% by week 30 when lectin intake stays near zero.
The protocol’s three 70-day cycles deliberately pair smart tirzepatide cycling with Japanese-style walking intervals, red light therapy, and our Brown Detox Drops to support liver and hormone pathways. For those managing joint pain or diabetes alongside Hashimoto’s, we start at 2.5 mg tirzepatide weekly, never exceeding 5 mg, while emphasizing 40–60 grams of net carbs from approved vegetables. This prevents the metabolic stall many experience on standard keto. Non-scale victories—better energy by week 4, reduced brain fog, looser clothing—matter more than the number on the scale. Patients who previously failed every diet regain confidence as labs normalize without insurance-covered programs.
Request a complete panel including TSH, free T3, free T4, reverse T3, TPO, TgAb, fasting insulin, HbA1c, hs-CRP, and a full lipid panel. Compare pre- and post-diet results against symptom trends rather than population “normal” ranges. If TSH climbs above 4.0 mIU/L with fatigue, we adjust thyroid medication upward by 12.5–25 mcg while continuing the protocol. Most clients end the 30 weeks with improved Hashimoto’s markers, 30–90 lb loss, and the metabolic freedom that ends yo-yo dieting. Focus on root causes—lectin-driven gut inflammation, toxin burden, and broken hunger signals—rather than chasing perfect numbers. The result is lasting health without medication dependency.